Bendamustine As Salvage Therapy in Multiple Myeloma: A Retrospective, Multicenter Study From the Italian Compassionate Use Program in 78 Heavily Pre-Treated Patients

被引：1
|
作者：
Musto, Pellegrino [1 ]
Fraticelli, Vincenzo Ludovico [2 ]
Mansueto, Giovanna [1 ]
D'Arena, Giovanni [1 ]
Petrilli, Maria Pia [2 ]
Gasbarrino, Cristiana [2 ]
Farina, Giuliana [2 ]
Guariglia, Roberto [1 ]
Martorelli, Maria Carmen [1 ]
Villani, Oreste [1 ]
Pietrantuono, Giuseppe [1 ]
Catalano, Lucio [3 ]
Madonna, Emanuela [3 ]
Nozza, Andrea [3 ]
Andriani, Alessandro [3 ]
Montefusco, Vittorio [3 ]
Mussetti, Alberto [3 ]
Lipari, Maria Grazia [3 ]
Ballanti, Stelvio [3 ]
Bongarzoni, Velia [3 ]
Tamiazzo, Stefania [3 ]
Patriarca, Francesca [3 ]
Vincelli, Donatella [3 ]
Falcone, Antonietta [3 ]
Derudas, Daniele [3 ]
Califano, Catello [3 ]
Zambello, Renato [3 ]
Mele, Giuseppe [3 ]
Fragasso, Alberto [3 ]
Baldini, Luca [3 ]
Palumbo, Antonio [4 ]
Storti, Sergio [2 ]
机构：
[1] IRCCS, CROB, Rionero In Vulture, Pz, Italy
[2] UOC Oncohematol, Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy
[3] GIMEMA Multiple Myeloma Working Party & Italian M, Rome, Italy
[4] Univ Turin, Div Hematol, Myeloma Unit, Turin, Italy
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.2971.2971
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2971
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Weekly topotecan as a salvage therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer
    Marinaccio, M.
    De Marino, E.
    Mele, E.
    Catacchio, R.
    Meo, D.
    Iezzoni, C.
    Conversano, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Topoisomerase inhibitors: Combination of irinotecan and epirubicin is feasible as salvage therapy for heavily pre-treated advanced lung cancer patients
    Malik, S
    Min, F
    Hwang, J
    Marshall, J
    LUNG CANCER, 2005, 49 : S257 - S257
  • [23] METRONOMIC ORAL CYCLOPHOSPHAMIDE IN THE SALVAGE TREATMENT OF HEAVILY TREATED OVARIAN CANCER PATIENTS: A RETROSPECTIVE, MULTICENTER STUDY
    Corrado, G.
    Mascilini, F.
    Savarese, A.
    Samaritani, R.
    Salutari, V.
    Di Stefano, M.
    Malaguti, P.
    Vizza, E.
    Scambia, G.
    Ferrandina, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [24] Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study
    Ferrandina, Gabriella
    Salutari, Vanda
    Vincenzi, Bruno
    Marinaccio, Marco
    Naglieri, Emanuele
    Loizzi, Vera
    Carpano, Silvia
    Amadio, Giulia
    Tonini, Giuseppe
    Scambia, Giovanni
    Lorusso, Domenica
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 505 - 510
  • [25] CarbOplatin in Metastatic castrate resistant ProstAte Cancer - a reTrospective study of heavily pre-treated patients (COMPACT)
    Pemberton, Lara
    Allen, Connor
    Handel, Eleanor
    Weickhardt, Andrew
    Shapiro, Jeremy
    Tran, Ben
    Taylor, Renea
    Risbridger, Gail
    Pook, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 : 61 - 61
  • [26] Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study
    Asmane, Irene
    Kurtz, Jean-Emmanuel
    Bajard, Agathe
    Guastalla, Jean-Paul
    Meeus, Pierre
    Tredan, Olivier
    Galy, Intidhar Labidi
    Moullet, Isabelle
    Ardisson, Philippe
    Vincent, Lionel
    Coeffic, David
    Dufresne, Armelle
    Bergerat, Jean-Pierre
    Ray-Coquard, Isabelle
    BULLETIN DU CANCER, 2011, 98 (09) : E80 - E89
  • [27] Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
    P A Thompson
    H M Prince
    J F Seymour
    D Ritchie
    K Stokes
    K Burbury
    M Wolf
    S Peinert
    T Joyce
    S J Harrison
    Bone Marrow Transplantation, 2011, 46 : 764 - 765
  • [28] Bortezomib added to high-dose melphalan as pre-transplant conditioning is safe in patients with heavily pre-treated multiple myeloma
    Thompson, P. A.
    Prince, H. M.
    Seymour, J. F.
    Ritchie, D.
    Stokes, K.
    Burbury, K.
    Wolf, M.
    Peinert, S.
    Joyce, T.
    Harrison, S. J.
    BONE MARROW TRANSPLANTATION, 2011, 46 (05) : 764 - 765
  • [29] A 'real-world' study of panobinostat, bortezomib and dexamethasone in a very heavily pre-treated population of myeloma patients
    Bird, Sarah
    Sriskandarajah, Priya
    Kaiser, Martin
    Pawlyn, Charlotte
    Boyd, Kevin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E244 - E245
  • [30] Single-agent gemcitabine in patients with advanced, pre-treated angiosarcoma: A multicenter, retrospective study
    Watson, Sarah
    Verret, Benjamin
    Ropert, Stanislas
    Adam, Julien
    Bahleda, Rastislav
    Briand, Sylvain
    Cavalcanti, Andrea
    Chamseddine, Ali N.
    Court, Charles
    Fadel, Elie
    Faron, Matthieu
    Haddag-Miliani, Leila
    Henon, Clemence
    Le Pechoux, Cecile
    Levy, Antonin
    Mercier, Olaf
    Ngo, Carine
    Honore, Charles
    Le Cesne, Axel
    Mir, Olivier
    CANCER MEDICINE, 2023, 12 (03): : 3160 - 3166
12345